Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2023-01-09
2024-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is in how far brain and glycemic responses differ between a sugar-sweetened drink and drinks sweetened with different low-caloric sweeteners.
Participants will visit after an overnight fast six times and then have an MRI brain scan before and after consumption of 500 ml of one of the study drinks (beverage sweetened with sucrose or one of four non-caloric sweeteners, or water).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota
NCT02580110
Preliminary Effect of Food Processing and Sweeteners on Glycemic and Metabolic Measures
NCT05658757
Mapping the 'Sweet Brain' in Healthy Participants
NCT04162457
The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose
NCT02075333
Effect of Changes in Glucose Intake and Sweet Perception on Post Prandial Glycaemia
NCT03613935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To determine changes in brain activity in response to the ingestion of flavored waters sweetened with either the nutritive sugar sucrose or different low-caloric sweeteners.
Study design: Randomized crossover design with six treatments. Study population: 30 healthy, non-smoking, normal-weight individuals, aged between 18 and 30 years.
Intervention: Participants will be scanned using MRI before and after consumption of six 500-ml drinks: water; water + sucrose; water + sucralose; water + stevia extract; water + allulose + stevia; water + monk fruit extract. Regional cerebral blood flow (rCBF) and resting state functional MRI (rsfMRI) scans will be made at baseline and at t=5 and t=30 min. Additionally, gastric emptying of the drinks will be examined through gastric MRI at t=15, 25 and 45 min. Blood samples will be collected to measure changes in insulin and glucose levels at baseline and at t=5, 15, 30, 45 and 60 min for all sweet treatments. Participants will rate their appetite and thirst at baseline and at t=15, 25, 30, 45 and 60 min.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water
Ingestion of 500 ml of mineral water
Water (reference)
Ingestion of 500 ml mineral water
Sucrose
Ingestion of 500 ml of a flavored mineral water sweetened with sucrose
Sucrose
Ingestion of 500 ml of a flavored mineral water sweetened with sucrose
Sucralose
Ingestion of 500 ml of a flavored mineral water sweetened with sucralose
Sucralose
Ingestion of 500 ml of a flavored mineral water sweetened with sucralose
Stevia
Ingestion of 500 ml of a flavored mineral water sweetened with stevia extract
Stevia
Ingestion of 500 ml of a flavored mineral water sweetened with stevia extract
Monk fruit
Ingestion of 500 ml of a flavored mineral water sweetened with monk fruit extract
Monk fruit
Ingestion of 500 ml of a flavored mineral water sweetened with monk fruit extract
Allulose + stevia
Ingestion of 500 ml of a flavored mineral water sweetened with allulose and stevia extract
Allulose + stevia
Ingestion of 500 ml of a flavored mineral water sweetened with allulose and stevia extract
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water (reference)
Ingestion of 500 ml mineral water
Sucrose
Ingestion of 500 ml of a flavored mineral water sweetened with sucrose
Sucralose
Ingestion of 500 ml of a flavored mineral water sweetened with sucralose
Stevia
Ingestion of 500 ml of a flavored mineral water sweetened with stevia extract
Monk fruit
Ingestion of 500 ml of a flavored mineral water sweetened with monk fruit extract
Allulose + stevia
Ingestion of 500 ml of a flavored mineral water sweetened with allulose and stevia extract
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 and 25 kg/m2
* Apparently healthy (self-reported)
* Right-handed (because brain responses may differ between right- and left handed individuals)
* Sufficient blood hemoglobin (Hb) levels (women \> 7,5; men \> 8.5 g/dl) and having antecubital veins suitable for blood sampling via a catheter
* Willing to comply with the study procedures
* Willing to be informed about incidental findings of pathology and consenting to informing their general practitioner about this.
Exclusion Criteria
* Use of medication that could influence study results including insulin/metformin/proton pump inhibitors, antacids, anti-depressants
* Allergy or intolerance for any of the study products/compounds (sucrose, sucralose, stevia extract, allulose, monk fruit extract)
* Being a regular smoker (smoking more than one cigarette or e-cigarette with nicotin per day)
* Drinking more than 14 glasses of alcohol a week
* Having genetic, psychiatric or neurological diseases affecting the brain
* Gastric disorders or regular gastric complaints (more than once per week), for example heart burn
* Having renal or hepatic disease
* Using recreational drugs more than once per week (e.g. marihuana, XTC, GHB, laughing gas)
* Having given a blood donation in the past two months
* Being pregnant, lactating or planning on becoming pregnant during the study
* Currently following or having followed calorie-restricted diet in the past two months
* Participating in other research during the study period
* Not having a general practitioner
* Being an employee or student of the Division of Human Nutrition and Health
* Having a contra-indication to MRI scanning
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tate & Lyle
INDUSTRY
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Smeets
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Smeets, PhD
Role: PRINCIPAL_INVESTIGATOR
Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Research Unit - Division of Human Nutrition and Health
Wageningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL81742.091.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.